Skip to Main Content
Contribute Try STAT+ Today
Trending:
Coronavirus
Health
Biotech
First Opinion
The Readout

Moderna’s patent problems & clocking the CRISPR race

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan May 17, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for May 17, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana covers biotech and contributes to The Readout newsletter.

Trending
Second U.S. case of Omicron variant indicates domestic transmission
Second U.S. case of Omicron variant indicates domestic transmission
The Fifth Circuit Court got the science wrong on…
The Fifth Circuit Court got the science wrong on OSHA’s vaccination mandate
vaccine silhouette
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and…
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Recommended
The READOUT
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The READOUT
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
The READOUT
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories

The READOUT
The Readout

Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs

By Meghana Keshavan

The READOUT
The Readout

Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue

By Damian Garde

Blood test droplet
In the Lab

Liquid biopsies could help screen for countless cancers. But who should get them?

By Angus Chen

Health

Injecting cancer patients with genetically engineered viruses could be a ‘rock star’ therapy. Why hasn’t it taken off?

By Marion Renault

Wall Street Hospital
A STAT Investigation

How America’s largest Catholic hospital system is moonlighting as a private equity firm

By Rachel Cohrs